< Terug naar vorige pagina
Onderzoeker
Ghesquiere Bart
- Disciplines (Flanders Institute for Biotechnology):Analyse van next-generation sequence data, Celdood, Kankerbiologie, (Bio)moleculaire modellering en design, Analytische biochemie, Auto-ecologie, Biogeografie en fylogeografie, Antropologische genetica, Bacteriologie, Celdood en senescentie, Epigenomics, Milieuveiligheid en gezondheid van nanotechnologie, Medische biofysica, Algemene diagnostiek, Adaptieve immunologie, Gedragsneurowetenschappen
- Disciplines (KU Leuven):Metabolomics, Scheidingstechnieken, Spectrometrie, Metabole regeling
- Zie ook: Bart Ghesquière (KU Leuven)
Affiliaties
- Metabolomics Expertisecentrum (VIB-KU Leuven) (Afdeling)
Verantwoordelijke
Vanaf1 okt 2016 → Heden - VIB Metabolomics Core Leuven (Core Labo)
Verantwoordelijke
Vanaf1 sep 2017 → Heden - VIB-KU Leuven Center for Cancer Biology (Onderzoekscentrum)
Verantwoordelijke
Vanaf1 sep 2017 → Heden - Ghesquière Lab (Onderzoeksgroep)
Verantwoordelijke
Vanaf1 sep 2017 → Heden - VIB Metabolomics Core Leuven (Core Labo)
Verantwoordelijke
Vanaf1 jan 2017 → Heden - Metabolomics Expertisecentrum (VIB-KU Leuven) (Afdeling)
Lid
Vanaf1 okt 2016 → 30 sep 2022 - Laboratorium voor Angiogenese en Vasculair Metabolisme (VIB-KU Leuven) (Afdeling)
Lid
Vanaf1 jan 2012 → 30 sep 2014
Projecten
1 - 5 of 5
- Tracer Raman-Driven Mass Spectrometry Imaging (TRaMaSI): a new platform for on-tissue Tracing of Nutritional and Biochemical Trajectories.Vanaf1 mei 2024 → HedenFinanciering: HORIZON.1.2 - Marie Skłodowska-Curie-acties (MSCA)
- VIB Grant for Ghesquière Lab_Period:2022-01-01-2026-12-31Vanaf1 jan 2022 → HedenFinanciering: VOI - Projectmatig onderzoek
- BE19-COMMUNITYLED (Bestaat uit de projecten GALAXY en PLANTS en gedeelte voor BaGh)Vanaf1 jun 2019 → 31 mei 2021Financiering: EMBL
- 'Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions’ — ‘COLOSSUS’Vanaf1 jan 2018 → 31 dec 2022Financiering: Andere Eu-programma's en intiatieven
- VIB Grant for Ghesquière Lab_Period:2018-01-01-2021-12-31Vanaf1 jan 2018 → 31 dec 2021Financiering: VOI - Projectmatig onderzoek
Publicaties
1 - 10 van 75
- Glycosphingolipids in congenital disorders of glycosylation (CDG).(2024)
Auteurs: Andrea Jáñez Pedrayes, Bart Ghesquière
Pagina's: 108434 - Ischemia-Induced Metabolic Patterns Associate With Kidney Function During Normothermic Kidney Perfusion, a Preclinical Study.(2024)
Auteurs: Julie De Beule, Laurence Verstraeten, Bart Ghesquière
Pagina's: e-pub - Reductive carboxylation epigenetically instructs T cell differentiation.(2023)
Auteurs: Bart Ghesquière
Pagina's: 849-856 - CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer.(2023)
Auteurs: Bart Ghesquière
Pagina's: 414-427 - Intracellular BAPTA directly inhibits PFKFB3, thereby impeding mTORC1-driven Mcl-1 translation and killing MCL-1-addicted cancer cells.(2023)
Auteurs: Guy Eelen, Mieke Dewerchin, Bart Ghesquière
Pagina's: 600 - Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1a-mediated glycolytic reprogramming.(2023)
Auteurs: Bart Ghesquière
Pagina's: 6858 - 13C tracer analysis reveals the landscape of metabolic checkpoints in human CD8+ T cell differentiation and exhaustion.(2023)
Auteurs: Bart Ghesquière
Pagina's: 1267816 - Current Insights into the Metabolome during Hypothermic Kidney Perfusion-A Scoping Review.(2023)
Auteurs: Laurence Verstraeten, Bart Ghesquière
Pagina's: 3613 - Glucocorticoid dysfunction in children with severe malaria.(2023)
Auteurs: Bart Ghesquière
Pagina's: 1187196 - Mitochondria metabolism sets the species-specific tempo of neuronal development.(2023)
Auteurs: Ryohei Iwata, Pierre Casimir, Emir Erkol, Leila Boubakar, Isabel Maria Gallego Lopez, Anke Vandekeere, Nikky Corthout, Massimiliano Mazzone, Stein Aerts, Bart Ghesquière, et al.
Pagina's: eabn4705
Patenten
1 - 5 van 5
- METHODS FOR ANALYZING THE PERFUSATE OF AN EX SITU MACHINE PERFUSED KIDNEY (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)